Skip to content

Decrease Flow during Menses Or Irregular Menstrual Cycle

Clinical Study Of Qillat Tams(Oligomenorrhea) and Its Management With Unani Formulation - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066227
Enrollment
40
Registered
2024-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

Intervention1: Jawarish-e-Qurtum: Oral administration of Jawarish-e-Qurtum 7gm in morning For 10 Days in Each Menstrual Cycle Control Intervention1: Not Applicable: Not Applicable

Sponsors

PG department of obstetrics and Gynecology Imul Qabalat wa Amraz E Niswan
Lead Sponsor
Government Nizamia Tibbi college and General Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age: patients from menarche to 35 years of age. 2)Unmarried and Married (Nulliparous,Multiparous) 3)Patients with infrequent menstrual periods of more than 35days. 4)Patient with scanty flow both in amount and duration. 5) PCOS 6) Hypothyroidism.

Exclusion criteria

Exclusion criteria: 1)Patients of age above 35 years . 2) Pregnant women and lactating mothers. 3) Severe systemic diseases such as HTN, DM, CVS, Respiratory diseases.

Design outcomes

Primary

MeasureTime frame
Pictorial Blood Loss Assessment Chart (PBAC score)Timepoint: Each patient Outcomes Depends on After 3 Cycles Of Oral Medicine i.e 30 Days, 10 Days In Each Month

Secondary

MeasureTime frame
Restoration of Normal Menstrual CycleTimepoint: Each patients outcome depends on 3 successful cycle of oral medicine i.e 30 Days ,10 Days in Each Month

Countries

India

Contacts

Public ContactDr Saleha Sultana

Govt Nizamia Tibbi College and General Hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026